KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Opko Health (OPK) over the last 16 years, with Q2 2025 value amounting to $788.0 million.

  • Opko Health's Shares Outstanding (Weighted Average) rose 1224.59% to $788.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $788.0 million, marking a year-over-year increase of 1224.59%. This contributed to the annual value of $694.0 million for FY2024, which is 768.14% down from last year.
  • As of Q2 2025, Opko Health's Shares Outstanding (Weighted Average) stood at $788.0 million, which was up 1224.59% from $671.6 million recorded in Q1 2025.
  • In the past 5 years, Opko Health's Shares Outstanding (Weighted Average) ranged from a high of $788.0 million in Q2 2025 and a low of $640.9 million during Q1 2021
  • Its 5-year average for Shares Outstanding (Weighted Average) is $705.8 million, with a median of $706.9 million in 2024.
  • In the last 5 years, Opko Health's Shares Outstanding (Weighted Average) skyrocketed by 1511.92% in 2022 and then tumbled by 768.14% in 2024.
  • Opko Health's Shares Outstanding (Weighted Average) (Quarter) stood at $648.1 million in 2021, then grew by 10.95% to $719.1 million in 2022, then increased by 4.55% to $751.8 million in 2023, then decreased by 7.68% to $694.0 million in 2024, then rose by 13.54% to $788.0 million in 2025.
  • Its last three reported values are $788.0 million in Q2 2025, $671.6 million for Q1 2025, and $694.0 million during Q4 2024.